InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
4
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-35.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Casdin Eli, Director. Officer active across 8 companies, notably GeneDx Holdings Corp.. Aggregated, 32 filings have been recorded. Split: 4 buys · 0 sell. Total volume traded: €73.3m. History available since 22 July 2021. The latest transaction was disclosed on 26 February 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Casdin Eli
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
99,116 sharesCommon StockSEC:0001193125-26-279828:0
3,576 sharesClass A Common StockSEC:0001534264-26-000002:0
52,991 shares@ US$1.179.7% of flowCommon StockSEC:0001193125-26-086197:0
12,924 shares0Class A Common StockSEC:0000919574-25-004391:0
94,592 shares0Common StockSEC:0000950170-25-089651:0
12,924 shares0Class A Common StockSEC:0001415889-25-017994:0
1,588 shares0Common StockSEC:0000950170-24-085790:0
43,128 shares0Common StockSEC:0000950170-24-080723:0
5,828 shares0Class A Common StockSEC:0001415889-24-018070:0
22,800 shares@ US$2.5010.8% of flowCommon StockSEC:0000950170-24-018893:0
3,807 sharesCommon StockSEC:0001104659-24-002655:0
3,430 sharesCommon StockSEC:0001209191-24-001324:0
8,659,372 shares0Common StockSEC:0000919574-23-006265:0
26,376 shares0Common StockSEC:0001162194-23-000048:0
250,000 shares@ US$1.886289.2% of flowCommon StockSEC:0000919574-23-003426:0
Canonical exit: 15 Aug 2023 (T+90)
45,454 shares0Class A Common StockSEC:0001209191-23-027315:0
3,430 shares0Common StockSEC:0001213900-23-021841:0
71,428,542 shares@ US$0.35100.0% of flowClass A Common StockSEC:0000899243-23-003400:0
Canonical exit: 1 May 2023 (T+90)
215,193 sharesClass A Common StockSEC:0000919574-22-007074:0
2,492,042 shares@ US$2.60100.0% of flowCommon StockSEC:0000919574-22-006902:0
Canonical exit: 15 Feb 2023 (T+90)
30,914 shares0Common StockSEC:0001162194-22-000076:0
12,836 sharesClass A Common StockSEC:0001209191-22-028687:0
11,437,500 shares@ US$4.00100.0% of flowClass A Common StockSEC:0001213900-22-023579:0
Canonical exit: 28 Jul 2022 (T+90)
15,852 shares0Common StockSEC:0000950142-22-001324:0
3,430 shares0Common StockSEC:0001062993-22-006752:0
25 of 32 declarations
About Casdin Eli
Casdin Eli is a Director at Standard Biotools INC., GeneDx Holdings Corp., SomaLogic, Inc., Sema4 Holdings Corp., and Tenaya Therapeutics, Inc. His 32 filings cover attribution transactions, with EUR 73,262,162 in purchases and EUR 0 in sales in the recent filings tracked, over the period from 2021-06-22 to 2026-06-23.
